MedStar Authors catalog › Details for: Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives. [Review]
Normal view MARC view ISBD view

Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives. [Review]

by Kitabata, Hironori; Waksman, Ron.
Citation: Cardiovascular Revascularization Medicine. 15(2):109-16, 2014 Mar..Journal: Cardiovascular revascularization medicine : including molecular interventions.ISSN: 1878-0938.Full author list: Kitabata H; Waksman R; Warnack B.UI/PMID: 24684760.Subject(s): *Absorbable Implants | Animals | Coronary Artery Disease/di [Diagnosis] | *Coronary Artery Disease/th [Therapy] | Drug-Eluting Stents | Endovascular Procedures/ae [Adverse Effects] | *Endovascular Procedures/is [Instrumentation] | Humans | Metals | Percutaneous Coronary Intervention/ae [Adverse Effects] | *Percutaneous Coronary Intervention/is [Instrumentation] | Peripheral Arterial Disease/di [Diagnosis] | *Peripheral Arterial Disease/th [Therapy] | Prosthesis Design | *Stents | *Tissue Scaffolds | Treatment OutcomeInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal Article | ReviewDigital Object Identifier: http://dx.doi.org/10.1016/j.carrev.2014.01.011 (Click here) Abbreviated citation: Cardiovasc Revasc Med. 15(2):109-16, 2014 Mar.Local Holdings: Available in print through MWHC library: 2002 - present.Abstract: Over the last decade, the introduction of drug-eluting stents has dramatically reduced restenosis and the need for repeat revascularization after implantation of metallic stents. Numerous concerns still remain, however, because of their permanent nature. Thus, the concept of bioresorbable temporary scaffolds composed of biocompatible materials has emerged as a potential alternative to permanent metal stents. Here we focus on metal alloys & discuss preclinical and clinical experiences with bioresorbable metal scaffolds. Copyright © 2014. Published by Elsevier Inc.

Powered by Koha